Kissei Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Kissei Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Kissei Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Kissei Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Kissei Pharmaceutical Co Ltd (Kissei) is a pharmaceutical company. The company's product portfolio includes medicines for urological, metabolic, endocrinological, obstetrics and gynecological, nephrological, ophthalmic, and pulmonary system disorders. The company sells protein-controlled foods, foods for the elderly and people receiving nursing care and energy supply foods. It also provides manufacturing and selling of noodle products, system integration and resource services, general construction and building management, information gathering and development support services. The company has sales offices across Japan and an overseas subsidiary in New Jersey, the US. Kissei is headquartered in Matsumoto-Shi, Nagano, Japan.
Headquarters
Japan
Address
19-48, Yoshino, Matsumoto, Nagano, 399-8710
Website
www.kissei.co.jp
Telephone
81 263 259081
No of Employees
1,786
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4547 (TYO)
Revenue (2025)
$625.9M
10.3%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
15.2%
(2025 vs 2024)
Market Cap*
$1.2B
Net Profit Margin (2025)
XYZ
4.5%
(2025 vs 2024)
* As of and is in US$
Kissei Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Pipeline (In-House): | System Integration Services | Beova |
| CG0070: Non-Muscle-Invasive Bladder Cancer | System Resource Services | Urief |
| Linzagolix/KLH-2109: Uterine Fibroids and Endometriosis | General Construction Services | Minirin Melt |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Corporate Changes/Expansions | In April, Kissei America, Inc. opened a new office, the Boston Open Innovation Office, in the Boston area of Massachusetts, the US. |
| 2024 | New Products/Services | In October, the company launched the Small Molecule Analysis and Separation Platform. |
| 2024 | Contracts/Agreements | In September, the company entered into an agreement with Rigel Pharmaceuticals to develop and market REZLIDHIA in Japan. |
Competitor Comparison
| Key Parameters | Kissei Pharmaceutical Co Ltd | Chugai Pharmaceutical Co Ltd | Tsumura & Co | Mochida Pharmaceutical Co Ltd | Kaken Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Matsumoto | Chuo-Ku | Minato | Shinjuku-Ku | Bunkyo-Ku |
| State/Province | Nagano | Tokyo | Tokyo | Tokyo | Tokyo |
| No. of Employees | 1,786 | 7,872 | 4,272 | 1,479 | 1,114 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mutsuo Kanzawa | Director; Chairman; Chief Executive Officer | Executive Board | 2014 | - |
| Yasuo Takehana | Director; Chief Operating Officer; President | Executive Board | 2022 | 62 |
| Tetsu Takayama | Executive Managing Director; Director | Executive Board | 2022 | 61 |
| Takahide Kitahara | Managing Director | Executive Board | 2022 | 61 |
| Keiji Fukushima | Director; Executive Vice President | Executive Board | 2022 | 67 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer